Literature DB >> 8044739

The prevalence of dementia in the elderly: a review.

K Rockwood1, K Stadnyk.   

Abstract

We reviewed the findings of the Canadian Study of Health and Aging in the context of studies published between January 1986 and June 1993 that documented dementia and Alzheimer's disease prevalence. Studies were identified using a MEDLINE literature search. Additional references were selected from the bibliography of identified articles. Most reports of all types of dementia prevalence are within a narrow range for each of the age groups 65+, 75+ and 85+ years. By contrast, two recent reports on the prevalence of Alzheimer's disease have reported much higher estimates (10.3% and 15.3%) in the elderly (65+ years). A variety of threats to both validity and generalizability of the estimates are present in all studies. In community studies which employed clinical interviews most subjects were only mildly affected; the natural history of impairment of this group requires further study if the consequences of these findings are to be understood. There is important variability in the definition of the functional consequences of cognitive impairment in the elderly which affects both the diagnosis and staging of dementia.

Entities:  

Mesh:

Year:  1994        PMID: 8044739     DOI: 10.1177/070674379403900503

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  7 in total

1.  Prevalence and correlates of dementia: survey of the last days of life.

Authors:  K G Losonczy; L R White; D B Brock
Journal:  Public Health Rep       Date:  1998 May-Jun       Impact factor: 2.792

2.  The association of age with rate of cognitive decline in elderly individuals residing in supporting care facilities.

Authors:  Ramit Ravona-Springer; Xiaodong Luo; James Schmeidler; Michael Wysocki; Gerson T Lesser; Michael A Rapp; Karen Dahlman; Hillel T Grossman; Vahram Haroutunian; Michal Schnaider Beeri
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Oct-Dec       Impact factor: 2.703

Review 3.  The pharmacoeconomics of dementia therapies. Bringing the clinical, research and economic perspectives together.

Authors:  F J Molnar; W B Dalziel
Journal:  Drugs Aging       Date:  1997-03       Impact factor: 3.923

Review 4.  Worldwide prevalence and incidence of dementia.

Authors:  L Fratiglioni; D De Ronchi; H Agüero-Torres
Journal:  Drugs Aging       Date:  1999-11       Impact factor: 4.271

5.  Vascular cognitive impairment: Current concepts and Indian perspective.

Authors:  Suvarna Alladi; Subhash Kaul; Shailaja Mekala
Journal:  Ann Indian Acad Neurol       Date:  2010-12       Impact factor: 1.383

6.  Optical Coherence Tomography: Is Really a New Biomarker for Alzheimer's Disease?

Authors:  Ceren Poroy; Ahmet Âli Yücel
Journal:  Ann Indian Acad Neurol       Date:  2018 Apr-Jun       Impact factor: 1.383

7.  Validity and reliability of the Arabic version of activities of daily living (ADL).

Authors:  Ramzi Nasser; Jacqueline Doumit
Journal:  BMC Geriatr       Date:  2009-03-29       Impact factor: 3.921

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.